메뉴 건너뛰기




Volumn 5, Issue 3, 2011, Pages 789-799

Analysis of the complete open reading frame of hepatitis C virus in genotype 2a infection reveals critical sites influencing the response to peginterferon and ribavirin therapy

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; THREONINE; VIRUS RNA;

EID: 80055025444     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-011-9267-x     Document Type: Article
Times cited : (10)

References (27)
  • 1
    • 65449136656 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C: An update
    • Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49(4):1335-1374
    • (2009) Hepatology , vol.49 , Issue.4 , pp. 1335-1374
    • Ghany, M.G.1    Strader, D.B.2    Thomas, D.L.3    Seeff, L.B.4
  • 3
    • 0031902847 scopus 로고    scopus 로고
    • Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection
    • Haydon GH, Jarvis LM, Blair CS, Simmonds P, Harrison DJ, Simpson KJ, Hayes PC. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 1998;42(4):570-575 (Pubitemid 28186578)
    • (1998) Gut , vol.42 , Issue.4 , pp. 570-575
    • Haydon, G.H.1    Jarvis, L.M.2    Blair, C.S.3    Simmonds, P.4    Harrison, D.J.5    Simpson, K.J.6    Hayes, P.C.7
  • 4
    • 0030907270 scopus 로고    scopus 로고
    • Clinical relevance of hepatitis C virus genotypes
    • Simmonds P. Clinical relevance of hepatitis C virus genotypes. Gut 1997;40(3):291-293 (Pubitemid 27145637)
    • (1997) Gut , vol.40 , Issue.3 , pp. 291-293
    • Simmonds, P.1
  • 6
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
    • DOI 10.1016/S0140-6736(01)06102-5
    • Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358(9286):958-965 (Pubitemid 32913521)
    • (2001) Lancet , vol.358 , Issue.9286 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3    Rustgi, V.K.4    Shiffman, M.5    Reindollar, R.6    Goodman, Z.D.7    Koury, K.8    Ling, M.-H.9    Albrecht, J.K.10
  • 7
    • 10644264391 scopus 로고    scopus 로고
    • Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: A pilot study
    • DOI 10.1002/hep.20467
    • Dalgard O, Bjoro K, Hellum KB, Myrvang B, Ritland S, Skaug K, Raknerud N, Bell H. Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study. Hepatology 2004;40(6):1260-1265 (Pubitemid 39656999)
    • (2004) Hepatology , vol.40 , Issue.6 , pp. 1260-1265
    • Dalgard, O.1    Bjoro, K.2    Hellum, K.B.3    Myrvang, B.4    Ritland, S.5    Skaug, K.6    Raknerud, N.7    Bell, H.8
  • 10
    • 47149083069 scopus 로고    scopus 로고
    • Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy
    • DOI 10.1002/hep.22339
    • El-Shamy A, Nagano-Fujii M, Sasase N, Imoto S, Kim SR, Hotta H. Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy. Hepatology 2008;48(1):38-47 (Pubitemid 351975529)
    • (2008) Hepatology , vol.48 , Issue.1 , pp. 38-47
    • El-Shamy, A.1    Nagano-Fujii, M.2    Sasase, N.3    Imoto, S.4    Kim, S.-R.5    Hotta, H.6
  • 14
    • 77952959964 scopus 로고    scopus 로고
    • Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load
    • Toyoda H, Kumada T, Tada T, Arakawa T, Hayashi K, Honda T, Katano Y, Goto H. Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load. J Gastroenterol Hepatol 2010;25(6):1072-1078
    • (2010) J Gastroenterol Hepatol , vol.25 , Issue.6 , pp. 1072-1078
    • Toyoda, H.1    Kumada, T.2    Tada, T.3    Arakawa, T.4    Hayashi, K.5    Honda, T.6    Katano, Y.7    Goto, H.8
  • 15
    • 77949353338 scopus 로고    scopus 로고
    • Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients
    • Donlin MJ, Cannon NA, Aurora R, Li J, Wahed AS, Di Bisceglie AM, Tavis JE. Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients. PLoS One 2010;5(2):e9032
    • (2010) PLoS One , vol.5 , Issue.2
    • Donlin, M.J.1    Cannon, N.A.2    Aurora, R.3    Li, J.4    Wahed, A.S.5    Di Bisceglie, A.M.6    Tavis, J.E.7
  • 16
    • 34547130793 scopus 로고    scopus 로고
    • Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy
    • DOI 10.1128/JVI.00487-07
    • Donlin MJ, Cannon NA, Yao E, Li J, Wahed A, Taylor MW, Belle SH, Di Bisceglie AM, Aurora R, Tavis JE. Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy. J Virol 2007;81(15):8211-8224 (Pubitemid 47101507)
    • (2007) Journal of Virology , vol.81 , Issue.15 , pp. 8211-8224
    • Donlin, M.J.1    Cannon, N.A.2    Yao, E.3    Li, J.4    Wahed, A.5    Taylor, M.W.6    Belle, S.H.7    Di Bisceglie, A.M.8    Aurora, R.9    Tavis, J.E.10
  • 17
    • 0032861258 scopus 로고    scopus 로고
    • Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection
    • DOI 10.1002/hep.510300405
    • Murakami T, Enomoto N, Kurosaki M, Izumi N, Marumo F, Sato C. Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection. Hepatology 1999;30(4):1045-1053 (Pubitemid 29458295)
    • (1999) Hepatology , vol.30 , Issue.4 , pp. 1045-1053
    • Murakami, T.1    Enomoto, N.2    Kurosaki, M.3    Izumi, N.4    Marumo, F.5    Sato, C.6
  • 18
    • 60049083515 scopus 로고    scopus 로고
    • Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy
    • Hayashi K, Katano Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy. J Med Virol 2009;81(3):459-466
    • (2009) J Med Virol , vol.81 , Issue.3 , pp. 459-466
    • Hayashi, K.1    Katano, Y.2    Honda, T.3    Ishigami, M.4    Itoh, A.5    Hirooka, Y.6    Nakano, I.7    Urano, F.8    Yoshioka, K.9    Toyoda, H.10    Kumada, T.11    Goto, H.12
  • 19
    • 0036117777 scopus 로고    scopus 로고
    • Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon
    • DOI 10.1016/S0002-9270(02)03975-8, PII S0002927002039758
    • Kobayashi M, Watanabe K, Ishigami M, Murase K, Ito H, Ukai K, Yano M, Takagi K, Hattori M, Kakumu S, Yoshioka K. Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon. Am J Gastroenterol 2002;97(4):988-998 (Pubitemid 34408259)
    • (2002) American Journal of Gastroenterology , vol.97 , Issue.4 , pp. 988-998
    • Kobayashi, M.1    Watanabe, K.2    Ishigami, M.3    Murase, K.4    Ito, H.5    Ukai, K.6    Yano, M.7    Takagi, K.8    Hattori, M.9    Kakumu, S.10    Yoshioka, K.11
  • 21
    • 0038649813 scopus 로고    scopus 로고
    • Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b
    • DOI 10.1111/j.1572-0241.2003.07469.x
    • Saito T, Ito T, Ishiko H, Yonaha M, Morikawa K, Miyokawa A, Mitamura K. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b. Am J Gastroenterol 2003;98(6):1377-1383 (Pubitemid 36741537)
    • (2003) American Journal of Gastroenterology , vol.98 , Issue.6 , pp. 1377-1383
    • Saito, T.1    Ito, T.2    Ishiko, H.3    Yonaha, M.4    Morikawa, K.5    Miyokawa, A.6    Mitamura, K.7
  • 22
    • 0141615503 scopus 로고    scopus 로고
    • Amino acid substitutions in PKR-elF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy
    • DOI 10.1016/S1386-6346(03)00164-5
    • Watanabe H, Nagayama K, Enomoto N, Itakura J, Tanabe Y, Sato C, Izumi N, Watanabe M. Amino acid substitutions in PKR-eIF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy. Hepatol Res 2003;26(4):268-274 (Pubitemid 37184514)
    • (2003) Hepatology Research , vol.26 , Issue.4 , pp. 268-274
    • Watanabe, H.1    Nagayama, K.2    Enomoto, N.3    Itakura, J.4    Tanabe, Y.5    Sato, C.6    Izumi, N.7    Watanabe, M.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.